{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T20:28:07Z","timestamp":1781468887083,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Italian Ministry of Public Health","award":["RC2010-2011"],"award-info":[{"award-number":["RC2010-2011"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.contraception.2013.02.001","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T12:46:03Z","timestamp":1362055563000},"page":"369-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM)"],"prefix":"10.1016","volume":"88","author":[{"given":"Rossella E.","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Terreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Sances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tonani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsenio","family":"Spinillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2013.02.001_bb0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0072-9752(10)97025-5","article-title":"Migraine and reproductive life","volume":"97","author":"Nappi","year":"2010","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.contraception.2013.02.001_bb0010","unstructured":"The international classification of headache disorders, 2nd ed. Cephalalgia 2004;(suppl 1)."},{"key":"10.1016\/j.contraception.2013.02.001_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/01.WNL.0000133134.68143.2E","article-title":"Prevalence of migraine on each day of the natural menstrual cycle","volume":"63","author":"MacGregor","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2013.02.001_bb0020","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.55.10.1517","article-title":"Menstrual cycle and headache in a population sample of migraineurs","volume":"55","author":"Stewart","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2013.02.001_bb0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1468-2982.1990.1006305.x","article-title":"Migraine and menstruation: a pilot study","volume":"10","author":"MacGregor","year":"1990","journal-title":"Cephalalgia"},{"key":"10.1016\/j.contraception.2013.02.001_bb0030","first-page":"239","article-title":"Estrogen-withdrawal migraine","volume":"25","author":"Sommerville","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2013.02.001_bb0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1468-2982.2003.00516.x","article-title":"Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment","volume":"23","author":"Couturier","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/j.contraception.2013.02.001_bb0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1468-2982.2004.00741.x","article-title":"Characteristics of menstrual and non-menstrual attacks in women with menstrually-related migraine","volume":"24","author":"Granella","year":"2004","journal-title":"Cephalagia"},{"key":"10.1016\/j.contraception.2013.02.001_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1783\/147118907781004750","article-title":"Migraine and use of combined hormonal contraceptives: a clinical review","volume":"33","author":"MacGregor","year":"2007","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2013.02.001_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1526-4610.2005.05049.x","article-title":"Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice","volume":"45","author":"Loder","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.contraception.2013.02.001_bb0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajog.2004.12.089","article-title":"Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review","volume":"193","author":"Loder","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2013.02.001_bb0060","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","article-title":"Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study","volume":"67","author":"MacGregor","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2013.02.001_bb0065","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1093\/humrep\/dei260","article-title":"Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval","volume":"20","author":"Nappi","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2013.02.001_bb0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.fertnstert.2011.07.1089","article-title":"Combined oral contraceptives in women with menstrual migraine without aura","volume":"96","author":"De Leo","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2013.02.001_bb0075","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"18","author":"Sulak","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2013.02.001_bb0080","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1526-4610.2011.02051.x","article-title":"Combined hormonal contraceptives: is it time to reassess their role in migraine?","volume":"52","author":"Calhoun","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.contraception.2013.02.001_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14737175.9.3.381","article-title":"Oral contraceptives in migraine","volume":"9","author":"Allais","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.contraception.2013.02.001_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2010.11.004","article-title":"The evolution of combined oral contraception: improving the risk-to-benefit ratio","volume":"84","author":"Burkman","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.02.001_bb0095","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","article-title":"The use of newer progestins for contraception","volume":"82","author":"Sitruk-Ware","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.02.001_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13625180902850039","article-title":"Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest","volume":"14","author":"Zeun","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2013.02.001_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.02.001_bb0110","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/der224","article-title":"Effective treatment of heavy and\/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial","volume":"26","author":"Fraser","year":"2011","journal-title":"Hum Reprod"},{"issue":"S1","key":"10.1016\/j.contraception.2013.02.001_bb0115","article-title":"Hormone withdrawal-associated symptoms (headache and pelvic pain) in women taking combined oral contraceptives: comparison of oestradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel","volume":"17","author":"Merki-Feld","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2013.02.001_bb0120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/jwh.2007.0440","article-title":"Menstrual-related pain conditions: dysmenorrhea and migraine","volume":"17","author":"Mannix","year":"2008","journal-title":"J Womens Health"},{"key":"10.1016\/j.contraception.2013.02.001_bb0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1468-2982.2006.01155.x","article-title":"Diaries and calendars for migraine. A review.","volume":"26","author":"Nappi","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.contraception.2013.02.001_bb0130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/11590220-000000000-00000","article-title":"Metabolic and haemostatc effects of estradiol valerate\/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study","volume":"31","author":"Junge","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2013.02.001_bb0135","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contracetive containing nomegestrol acetate and 17b-oestradiol compared with one containing levonorgestrel and ethynilestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2013.02.001_bb0140","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.fertnstert.2009.12.054","article-title":"Surrogate end points in women's health research: science, protoscience and pseudoscience","volume":"93","author":"Grimes","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2013.02.001_bb0145","article-title":"Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study","author":"Endrikat","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.02.001_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1526-4610.2006.00370.x","article-title":"Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis \u2014 part 2","volume":"46","author":"Martin","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.contraception.2013.02.001_bb0155","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1526-4610.2010.01657.x","article-title":"Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea","volume":"50","author":"Durham","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.contraception.2013.02.001_bb0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","article-title":"Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan\u2013naproxen: two randomized controlled trials","volume":"114","author":"Mannix","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2013.02.001_bb0165","first-page":"CD001751","article-title":"Nonsteroidal anti-inflammatory drugs for dysmenorrhoea","volume":"1","author":"Marjoribanks","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2013.02.001_bb0170","first-page":"CD000400","article-title":"Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding","volume":"4","author":"Lethaby","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2013.02.001_bb0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.maturitas.2012.01.018","article-title":"The pharmacology of dienogest","volume":"71","author":"Ruan","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2013.02.001_bb0180","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.fertnstert.2011.11.005","article-title":"Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture","volume":"97","author":"Yamanaka","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2013.02.001_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.contraception.2011.11.011","article-title":"Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate\/dienogest","volume":"86","author":"Fraser","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.02.001_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11916-011-0209-z","article-title":"Endometriosis and headache","volume":"15","author":"Stovner","year":"2011","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.contraception.2013.02.001_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-011-0153-6","article-title":"Menstrual migraine: update on pathophysiology and approach to therapy and management","volume":"14","author":"Calhoun","year":"2012","journal-title":"Curr Treat Options Neurol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782413000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782413000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:45:25Z","timestamp":1761432325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782413000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0010782413000450"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2013.02.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717987059.793472323","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM)","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2013.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}